发明名称 |
Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
摘要 |
A molded article, such as a tablet, for administration to an oral cavity of a subject to treat of prevent a cyclooxygenase-2 mediated condition, disorder or disease, the molded article comprising a moldable blend of a selective cyclooxygenase-2 inhibitory drug which may have the structure of general formula (I), with a pharmaceutically acceptable excipient carrier system consisting predominantly of one or more carbohydrates, wherein: (a) the selective cyclooxygenase-2 inhibitory drug is present in a total amount of about 20% to about 60% by weight of the molded article; (b) ingredients and amounts thereof in the molded article and a process for preparing the molded article are selected such that the molded article exhibits rapid disintegration in the oral cavity; and (c) the moldable blend in prepared by a process step not requiring wet granulation; a process for preparing the molded article; and the use of the molded article in the manufacture of a medicament for treating a medical condition or disorder in a mammalian subject where treatment with a cyclooxygenase-2 inhibitor is indicated.
|
申请公布号 |
NZ524124(A) |
申请公布日期 |
2004.09.24 |
申请号 |
NZ20010524124 |
申请日期 |
2001.08.17 |
申请人 |
PHARMACIA CORPORATION |
发明人 |
KARARLI, TUGRUL T;KONTNY, MARK J;LE, TRANG T |
分类号 |
C07D237/04;A61K9/00;A61K9/20;A61K31/341;A61K31/352;A61K31/415;A61K31/42;A61K31/444;A61K31/451;A61K31/485;A61K31/50;A61K45/08;A61K47/10;A61K47/26;A61K47/36;A61K47/38;A61P11/06;A61P19/02;A61P29/00;C07D213/61;C07D231/12;C07D261/08;C07D307/58;C07D311/58;(IPC1-7):A61K9/20;A61K31/635 |
主分类号 |
C07D237/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|